ANI Pharmaceuticals Earning Date (ANIP)

USA |NASDAQ |USD

ANIP Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 4, 2022 Jun 2022 - - $0.67
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 4, 2022 Jun 2022 - - $48.62M

Ani Pharmaceuticals's next earnings date is Thursday, Aug 4, 2022 for the fiscal quarter ending Jun 2022.

ANIP Earnings Date & History Chart

ANIP Earnings & Revenue Forecast

ANIP Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $4.38 $4.14 $4.56

ANIP Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 1 / 1 $3.87 $3.87 $4.12

ANIP Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $301.80M $250.60M $33.88M

ANIP Earnings Date & Revenue History

ANIP Earnings History

|
Show More
Show More

ANIP Revenue History

|
Show More
Show More

Ani Pharmaceuticals Next Earnings Date & Report

ANIP Next Earnings Date & Report Preview: Jun 2022 (FQ)

ANIP's next earnings date is Thursday, Aug 4, 2022 for the fiscal quarter ending Jun 30, 2022.

Ani Pharmaceuticals Previous Earnings Dates & Reports

ANIP Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Ani Pharmaceuticals's previous earnings date was May 10, 2022 for its fiscal quarter ended Mar 31, 2022.

ANIP Previous Earnings Date & Report Recap: Dec 2021 (FY)

Ani Pharmaceuticals's previous annual earnings date was Mar 15, 2022 for its fiscal year ended Dec 31, 2021.

ANIP's earnings per share (EPS) was $3.26, missing the consensus analysts forecast of $3.48 by -6.32% , and lower than the previous year's EPS (Dec 2020) by -6.86%.

Revenues were $216.14M, better than the forecast of $211.43M by 2.23%, and up by 3.67% from previous year's revenue.

The company reported a net income of $-69.51M.

Ani Pharmaceuticals reported a free cash flow of $-20.32M for its fiscal year, compared to $-53.05M a year ago.

The company ended the fiscal year with $286.52K in total debt, a decrease of -99.85% compared to the previous year.